Response to Dawson et al
- PMID: 32495823
- PMCID: PMC8494001
- DOI: 10.1093/infdis/jiaa315
Response to Dawson et al
Comment on
-
Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure.J Infect Dis. 2020 May 11;221(11):1752-1756. doi: 10.1093/infdis/jiaa152. J Infect Dis. 2020. PMID: 32232474 Free PMC article.
-
Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.J Infect Dis. 2020 Jul 6;222(3):514-516. doi: 10.1093/infdis/jiaa314. J Infect Dis. 2020. PMID: 32496536 Free PMC article. No abstract available.
References
-
- WHO Working Group for Guidance on Human Challenge Studies in COVID-19. Key criteria for the ethical acceptability of COVID-19 human challenge studies. Geneva, Switzerland: World Health Organization, 2020:20.
-
- Shah SK, Miller FG, Darton TC, et al. . Ethics of controlled human infection to study COVID-19. Science 2020; 368:832–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
